antitumor

(redirected from antitumour)
Also found in: Dictionary, Thesaurus.

antitumor

(ăn′tĭ-to͞o′mər, -tyo͞o′-) also

antitumoral

(-mər-əl)
adj.
Anticancer.

antitumor

(ant′ē-too″mŏr) [ anti- + tumor]
Inhibiting the growth or development of cancer.
Mentioned in ?
References in periodicals archive ?
The synergy is manifested both as increased antitumour efficacy, as well as less side effects from the chemotherapy.
Cantargia reports positive preclinical data for its anitibody CAN04 in bladder cancer treatment
Testing of Antitumour activity by potato disc assay
In-vitro Studies on Antitumour and Antimicrobial Activities of Methanolic Kernel Extract of Mangifera indica L. Cultivar Banganapalli
This study aims to evaluate the antitumour and antioxidant properties of Moroccan Berberis vulgaris.
Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine
These findings raise the possibility that, during the evolution toward the more aggressive forms, epithelial cells in E-MpMs acquire immune properties as a result of a transdifferentiation process, which is probably a mechanism underlying the evasion from an ongoing antitumour immune response [28].
Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types
We would like to highlight the phase III KEYNOTE-059 trial, as it showed antitumour activity and durable responses in patients with advanced gastric/GEJ cancer progression after more than 2 lines of therapy.
Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies
The results showed that cardiotoxicity was reduced and antitumour responses were increased, compared to free drug (Zeng et al.
Targeted drug delivery and vaccinology approaches using virus-like particles for cancer
Recently, antitumour effect was also observed with gamma irradiated M.
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer/Mesane Kanseri icin Immunoterapotik Potansiyele Sahip Mycobacterium Brumae Ekstresi Fraksiyonlari
(6) ITK inhibition by ibrutinib is believed to shift the balance between Th1 and Th2 T cells and enhance antitumour immune responses.
Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia
Yamada, Total Synthesis of an Antitumour Antibiotic,(+-)Reductionmycin., J.
Tandem Chlorination - Oxidation - Wittig Reactions: An Efficient Approach to (Z)-a-chloro-a,b-unsaturated esters
In this way, they possess antitumour efficacy in addition to their targeted impact.
Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
Accumulating lines of evidence have shown that API shows antitumour activity and induces apoptosis in many cancer cell lines in a dose-dependent manner [21, 22].
Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway
Concomitant targeting of MDSCs may therefore increase the antitumour activity of PD-1/PD-L1 inhibitors in nonresponders.
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

Medical browser ?
Full browser ?